ISouth African Health Products Regulatory Authority (SAHPRA) isikhiphe isexwayiso sokuthi kubuyiswe amaqoqo amane amaphilisi e-Arya Enalapril 10mg, asetshenziswa ukwelapha i-BP.
Lokhu kuhoxiswa kuza ngemuva kokuthi kutholakale imiphumela engahambisani namazinga adingekayo ngesikhathi sokuhlolwa okujwayelekile kokuphepha nokusebenza kwemishanguzo.
I-SAHPRA inxusa iziguli, ochwepheshe bezempilo, amakhemisi, abathengisi bemishanguzo ngobuningi kanye nabanye abahlinzeki ukuthi bahlole isitokwe sabo ngokushesha, bakhombe amaqoqo athintekile futhi balandele izinyathelo ezidingekayo zokubuyiselwa kwawo.
Le nqubo yokuhoxiswa yenziwa ngaphansi kwe-**Class II-Type A recall**, yi-Arya Pharma (Pty) Ltd ngokubonisana ne-SAHPRA, futhi ihambisana nomthetho olawula imithi nezinto ezihlobene nayo.
Izidingo zokubuyiswa kwala maqoqo zihlose ukuqinisekisa ukuphepha kweziguli nokuvikela ukusetshenziswa kwemikhiqizo engahambisani namazinga abekiwe.
